| #400 |
Benjamin Dawson Stevens |
Pfizer |
1 |
| #400 |
Ron J. Mann |
Broadcom |
1 |
| #400 |
Rames Martinez |
Harvard University |
1 |
| #400 |
Carl Elie Nehme |
MIT |
1 |
| #400 |
Carlos Pardo |
MIT |
1 |
| #400 |
Sebastian T. Le Quement |
Harvard University |
1 |
| #400 |
Lujian Tan |
Novartis Ag |
1 |
| #400 |
Hector Luis Penagos-Vargas |
— |
1 |
| #400 |
Yong-Ming Yu |
The General Hospital |
1 |
| #400 |
Daniela Fera |
Wistar Institute Of Anatomy And Biology |
1 |
| #400 |
J. Rajeev Ram |
MIT |
1 |
| #400 |
Ben Duong |
Airwatch |
1 |
| #400 |
Kristine Friesen |
Thermo Fisher |
1 |
| #400 |
Maurizio Nanni |
Silicon Laboratories |
1 |
| #400 |
Jason Bohland |
Siemens Healthcare Limited |
1 |
| #400 |
Johannes Kratz |
University of California |
1 |
| #400 |
Oak K. Kim |
Bristol-Myers Squibb |
1 |
| #400 |
Okuary Osechas |
Mitsubishi Electric |
1 |
| #400 |
Nickeisha A. Stephenson |
The General Hospital |
1 |
| #400 |
Matthias Eikermann |
The General Hospital |
1 |
| #400 |
Elena Geretti |
Merrimack Pharmaceuticals |
1 |
| #400 |
Kay Tye |
Stanford University |
1 |
| #400 |
Brock Wagenaar |
Tvworks |
1 |
| #400 |
Lidiya Mishchenko |
Harvard University |
1 |
| #400 |
Michael Mermelstein |
MIT |
1 |
| #400 |
Kabir James Mukaddam |
Formulatrix |
1 |
| #400 |
Michael M. Afergan |
Akamai Technologies |
1 |
| #400 |
Ioannis K. Zervantonakis |
Children'S Medical Center |
1 |
| #400 |
Guolong Su |
Texas Instruments |
1 |
| #400 |
Jingjing Ling |
MIT |
1 |
| #400 |
Alan Swartz |
Avid Technology |
1 |
| #400 |
Praveen Arany |
Harvard University |
1 |
| #400 |
Chenteh Kenneth Fan |
— |
1 |
| #400 |
Gary Vincent Palladino |
Kings Systems |
1 |
| #400 |
Anurag Bajpayee |
MIT |
1 |
| #400 |
Gilad Lotan |
Microsoft |
1 |
| #400 |
Brooks Edwards |
Tropix |
1 |
| #400 |
Mohammed Saeed |
Koniniklijke Philips N.V. |
1 |
| #400 |
William B. Kalb |
Harvard University |
1 |
| #400 |
Alexis S. TURJMAN |
— |
1 |
| #400 |
Taliesin Sebastian Beynon |
Wolfram Alpha |
1 |
| #400 |
John Trauger |
Novartis Ag |
1 |
| #400 |
Roger Diebold |
Harvard University |
1 |
| #400 |
George Scott Tria |
Novartis Ag |
1 |
| #400 |
Matthew M. Dedmon |
University Of North Carolina At Chapel Hill |
1 |
| #400 |
Karthik Iyer |
Cyclerion Therapeutics |
1 |
| #400 |
Matthew Blackshaw |
Dropbox |
1 |
| #400 |
Jonathan Harris Schechter |
Amazon |
1 |
| #400 |
Jonathan David Smith |
MIT |
1 |
| #400 |
Andre B. Charette |
Infinity Pharmaceuticals |
1 |